RenaSci Director to Present at Workshop on Drug Dependence at the CPDD

23/05/2016 11:15

Our expert on drug abuse and dependence, Professor David Heal, will be participating in the 78th Annual Meeting of the CPDD (College on Problems of Drug Dependence) which will be held at La Quinta Resort & Club, Palm Springs, California, USA, 11th to 16th June, 2016.

David will be speaking in Workshop XIII 'Regulatory and Methodological Considerations in the Evaluation of Drug Dependence in the Preclinical and Clinical Setting' to be held on Tuesday 14th June. The session will be chaired by Beatrice Setnik (INC Research) and Michael Klein (Controlled Substance Staff of the FDA). 

The title of the talk that David will be giving is 'An overview of preclinical models to assess physical and psychological dependence and their translation to the clinic'.

Other speakers at the workshop include Alicja Lerner (CSS,FDA); Jack Henningfield (Pinney Associates), and Sian Ratcliffe (Pfizer Inc). 

David will also be giving the following oral communications at the meeting:

Evaluation of the reinforcing effect of the κ-opioid receptor agonist CR845 using a self-administration procedure in heroin-maintained rats (to be presented at the ISGIDAR (International Study Group Investigating Drugs as Reinforcers) meeting on 11th June).

Investigation of the κ-opioid receptor agonist CR845 and reference comparator, butorphanol, in rats trained to discriminate (-) pentazocine from saline (to be presented on Tuesday 14th June, Abstract No. 232). 

Please contact us on if you would like to see David at the CPDD or for further information about our drug abuse liability testing services.